首页> 外文OA文献 >Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression
【2h】

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

机译:恶性没有永生?细胞永生化可能是黑色素瘤进展中的晚期事件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell senescence is a permanent growth arrest following extended proliferation. Cultured cancer cells including metastatic melanoma cells often appear immortal (proliferate indefinitely), while uncultured benign nevi (moles) show senescence markers. Here, with new explantation methods, we investigated which classes of primary pigmented lesions are typically immortal. Nevi yielded a few proliferating cells, consistent with most nevus cells being senescent. No nevus culture (0/28) appeared immortal. Some thin and thick melanoma cultures proved immortal under these conditions, but surprisingly few (4/37). All arrested cultures displayed three senescence markers in some cells: β-galactosidase, nuclear p16, and heterochromatic foci/aggregates. However, melanoma cultures also showed features of telomeric crisis (arrest because of ultrashort telomeres). Moreover, crisis markers including anaphase bridges were frequent in uncultured vertical growth-phase (VGP) melanomas. Conversely, all immortal melanoma cultures expressed telomerase reverse transcriptase and telomerase, showing aneuploidy. The findings suggest that primary melanomas are typically precrisis, with immortalization/telomere maintenance as a late event.
机译:细胞衰老是延长增殖后的永久性生长停滞。培养的癌细胞(包括转移性黑素瘤细胞)通常看起来是永生的(无限增殖),而未培养的良性痣(痣)则显示衰老标记。在这里,通过新的移植方法,我们调查了哪些类型的原发性色素性病变通常是不死的。 Nevi产生了一些增殖细胞,与大多数痣细胞正在衰老一致。没有痣文化(0/28)出现不朽。在这种情况下,一些稀薄的黑色素瘤培养物证明是永生的,但令人惊讶的是很少(4/37)。所有被捕的培养物在某些细胞中均显示出三个衰老标记:β-半乳糖苷酶,核p16和异色病灶/聚集体。但是,黑素瘤文化也表现出端粒危机的特征(由于超短端粒而被捕)。此外,在未培养的垂直生长阶段(VGP)黑色素瘤中,包括后期阶段桥梁在内的危机标志也很常见。相反,所有永生性黑色素瘤培养物均表达端粒酶逆转录酶和端粒酶,表现出非整倍性。这些发现表明原发性黑色素瘤通常是先兆性疾病,永生化/端粒维持是一种晚期事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号